Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProVita Biotech is a China-based supplier and manufacturer of nutraceutical and dietary supplement ingredients serving sports nutrition, anti-aging, and broader wellness markets. The company provides bulk raw materials, specialty ingredients, OEM/ODM services, formulation support, and R&D for supplement brands and manufacturers. Its offerings include liposomal delivery, microencapsulation, granular materials, and ingredient sourcing services designed to improve stability, bioavailability, and product performance. Rather than operating as a drug-development biotech with a therapeutic pipeline, ProVita Biotech appears to be a commercial-stage B2B health ingredients and manufacturing partner. The company markets a broad portfolio of compounds such as creatine ingredients, ergothioneine, urolithin A, fisetin, spermidine, and other nutraceutical actives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProVita.